The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectivenessBorja Gracia-Tello, Amara Ezeonyeji, David Isenberg
2 February 2017
Efficacy and tolerability of repository corticotropin injection in patients with persistently active SLE: results of a phase 4, randomised, controlled pilot studyRichard Furie, Margaret Mitrane, Enxu Zhao, Maya Das, Daner Li, Patrice M Becker
3 November 2016
Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosusB A Sullivan, W Tsuji, A Kivitz, J Peng, G E Arnold, M J Boedigheimer, K Chiu, C L Green, A Kaliyaperumal, C Wang, J Ferbas, J B Chung
8 April 2016
Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USAC E Collins, M Dall'Era, H Kan, C Macahilig, C Molta, V Koscielny, D J Chang
11 January 2016
Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II studyMurray B Urowitz, David A Isenberg, Daniel J Wallace
11 August 2015
Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohortK S Yap, M Northcott, A B-Y Hoi, EF Morand, M Nikpour
8 April 2015
Standard medical care of patients with systemic lupus erythematosus (SLE) in large specialised centres: data from the Russian Federation, Ukraine and Republic of Kazakhstan (ESSENCE)E Nasonov, S Soloviev, J E Davidson, A Lila, G Togizbayev, R Ivanova, Ch Baimukhamedov, Zh Omarbekova, O Iaremenko, A Gnylorybov, S Shevchuk, A Vasylyev, M H S Pereira
19 February 2015
